Medication info
Acyclovir Tablet (Acyclovir)

Acyclovir Tablet (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Seoul Pharmaceutical Co., Ltd.
Appearance
Light blue round tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199502649 · Notified 1995.08.04 · Insurance code 652901150

Summary

Main use
Treatment and prevention of herpes simplex, treatment of herpes zoster, treatment of chickenpox in children
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose, 5 times daily at 4-hour intervals for 5 days. For severe primary infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose, 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose, 2 ~ 3 times daily, after confirming its effectiveness. 3) To determine the natural course of the disease, treatment should be periodically discontinued for assessment every 6 ~ 12 months in patients receiving long-term treatment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose, 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose, 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Use caution in patients with renal impairment, as they are more likely to experience adverse reactions involving the central nervous system; consider extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 2 times daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 3 times daily at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as the adult dose. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are currently no reliable data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg of body weight per dose (maximum 800 mg per dose), 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
Seoul Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex, treatment of herpes zoster, treatment of chickenpox in children

  • Genital herpes
  • herpes simplex virus infection of the skin and mucosal tissues
  • herpes zoster virus infection
  • acute pain
  • chickenpox.
View approved original text

This medication is used to treat and prevent infections caused by the herpes simplex virus, including initial and recurrent genital herpes, affecting the skin and mucosal tissues. It is also effective in treating herpes zoster virus infections, particularly helping to relieve pain in the acute phase. However, its effectiveness for postherpetic neuralgia has not yet been conclusively proven. Additionally, it is used in the treatment of chickenpox in children over 2 years of age. Thus, it is utilized to treat various viral infections, improving symptoms and aiding in recovery.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose, 5 times daily at 4-hour intervals for 5 days. For severe primary infections, treatment may be extended. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose, 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered 2 times daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose, 2 ~ 3 times daily, after confirming its effectiveness. 3) To determine the natural course of the disease, treatment should be periodically discontinued for assessment every 6 ~ 12 months in patients receiving long-term treatment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose, 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose, 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Use caution in patients with renal impairment, as they are more likely to experience adverse reactions involving the central nervous system; consider extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 2 times daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose, 3 times daily at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as the adult dose. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are currently no reliable data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg of body weight per dose (maximum 800 mg per dose), 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication should not be used in patients who have had allergic reactions to this medication, its ingredients, or valacyclovir. It also contains lactose, so it should not be taken by patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndrome. Patients with impaired kidney function are at higher risk for neuropsychiatric side effects when using this medication, so caution is necessary. Patients with decreased liver function should use this medication cautiously as it may further impair liver function. Infants, children, and the elderly should be particularly cautious when administering this medication, and the minimal effective dose should be used if necessary. This medication can rarely cause serious allergic reactions such as anaphylactic shock, so if symptoms such as low blood pressure, breathing difficulties, or chest tightness occur, use should be discontinued immediately and emergency treatment sought. If skin rash, fever, blisters, or hives develop, use of this medication should be stopped, and appropriate treatment should be sought. Rarely, side effects such as hair loss, severe skin disorders, neuropsychiatric symptoms, kidney abnormalities, blood disorders, liver dysfunction, and gastrointestinal issues may occur, so if any unusual symptoms arise, consultation with medical personnel should be immediate. For treatment of herpes simplex and chickenpox, the medication should be taken for 5 days, and for herpes zoster, for 7 days. If symptoms do not improve or worsen, alternative treatments should be considered. Starting treatment as soon as symptoms appear is the most effective; for herpes zoster, treatment should begin within 5 days of skin symptom onset, and for chickenpox, within 3 days. Immunocompromised patients may consider intravenous treatment. To prevent dehydration and kidney damage during high doses, adequate fluid intake is essential. For prolonged and repeated use of this medication, consultation with medical personnel regarding continued use is necessary. This medication can cause disturbances in consciousness; caution should be exercised when driving or operating dangerous machinery, particularly in patients with impaired kidney function. When used with other medications, interactions may occur, so if taking other medications, it is essential to inform medical personnel. Women who are pregnant or may become pregnant should use this medication cautiously, as it may affect the fetus; breastfeeding should be suspended if taking this medication. In cases of overdose, serious side effects such as agitation, coma, or seizures may occur, and there is a risk of kidney damage, so caution is advised against overdose. If an overdose is suspected, seek medical attention immediately, and necessary treatments such as blood dialysis may be required. Animal studies have suggested that high doses may affect genetic abnormalities or reproductive function; however, these effects have not been reported at typical doses.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • respiratory distress
  • chest tightness
  • photophobia
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • increased serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • elevated blood pressure
  • lowered blood pressure
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol
  • increased triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

When used domestically, this medication should be stored in a well-closed container at room temperature between 1 degree and 30 degrees Celsius. When exported overseas, it is important to store it in an airtight container that blocks light in a dry place under 25 degrees Celsius. Proper storage can help maintain the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.